Delivery Order SPE2DB22D2214-SPE2DB24FS3TK
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,001.06 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary contract vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRESIBA FLEXTOUCH 100 UNIT/ML 3ML pharmaceutical products. The contract has a ceiling value of $2,289.66 and a period of performance through April 12, 2024. This delivery order is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a potential value of $30,469.74 and a completion date of March 8, 2024. The award is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The $2,166.52 firm fixed price contract has a May 3, 2024 completion date. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of...
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML insulin medication. The $18,948.75 firm-fixed-price contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,245.90 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Tresiba FlexTouch 200 unit/mL 3mL. The contract has a ceiling value of $2,071.71 and a period of performance through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order worth $1,334.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $4,402.92 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML medication. This order was placed under an existing indefinite delivery contract (IDC) held by Amerisourcebergen with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRESIBA FLEXTOUCH 200 UNIT/ML 3ML medical supplies. The $9,744.81 contract has a completion date of November 16, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS3TKDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4,563,803,876 units of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML. The delivery order is valued at $6,882.90 and has a completion date of February 29, 2024. This award is under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 2/28/24 |